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Abstract
Background: Developmental iodine deficiency (ID) leads to inadequate thyroid hormone that
impairs learning and memory with an unclear mechanism. Here, we show that hippocampal
extracellular signal-regulated kinase (ERK1/2) and cAMP response element-binding protein (CREB)
are implicated in the impaired learning and memory in lactational and adolescent rat hippocampus
following developmental ID and hypothyroidism.
Methods: Three developmental rat models were created by administrating dam rats with either
iodine-deficient diet or propylthiouracil (PTU, 5 ppm or 15 ppm)-added drinking water from
gestational day (GD) 6 till postnatal day (PN) 28. Then, the total and phorsporylated ERK1/2 and
total and phorsporylated CREB in the hippocampus were detected with western blot on PN14,
PN21, PN28 and PN42.
Results: The iodine-deficient and hypothyroid pups showed lower serum FT3 and FT4 levels,
smaller body size, and delayed eyes opening. The mean number of surviving cells in the
hippocampus of the iodine-deficient and 15 ppm PTU-treated rats was significantly reduced
compared to controls (P < 0.05). Iodine-deficient and 15 ppm PTU-treatment groups
demonstrated significantly lower level of total and phosphorylated ERK1/2 and CREB than the
controls on PN14, PN21 and PN28 (P < 0.05, respectively). The reduction of ERK1/2 and CREB
was not reversible with the restoration of serum thyroid hormone concentrations on PN42.
Conclusions: Developmental ID and hypothyroidism down-regulate hippocampal ERK1/2 and
CREB in lactational and adolescent rats.
Background
Iodine is an essential trace element and critical for the syn-
thesis of triiodothyronine (T3) and thyroxine (T4).
Thereby, iodine deficiency (ID) is the most common
cause of hypothyroidism worldwide particularly in the
developing countries [1]. In the process of early growth
and development of most organs, hypothyroidism results
in impaired brain development, cognitive deficits,
impaired memory, impaired cognitive function and inat-
tentiveness, and mental retardation in offspring [2-5].
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During these developmental periods, the mother is the
only source of iodine for the fetus [5-7]. Not until the day
of birth is the offspring able to make sufficient levels of its
own thyroid hormone. In line with this conclusion, recent
researches show that children born to mothers experienc-
ing subclinical perturbations of the thyroid axis during
pregnancy have lower IQ scores and subtle deficits in cog-
nition and memory [5,8,9]. Importantly, on one hand, ID
induces irreversible developmental alterations in the
fetuses and children central nervous system (CNS) [6]. On
the other hand, ID is one of the greatest preventable cause
of mental retardation and an important public-health
problem [10]. This has been proven true in China where,
after complying with Universal Salt Iodization (USI) in
1995, the ID disorders have been significantly reduced
[11]. However, we recently reported that 7 of all 31 Chi-
nese provinces or 400 counties with a population of 0.72
billion suffered from ID [11].
The hippocampus, a major component of the brain of
humans and other mammals, belongs to the limbic sys-
tem and plays important roles in long-term memory,
learning processes and spatial navigation. The structural
integrity of the hippocampus is dependent on sufficient
thyroid hormone during development [8]. The classical
genomic molecular mechanism of thyroid hormone is
well understood [12]. After the uptake of T3 or T4 by target
cells, T3 gains access to the cell nucleus and binds to
nuclear thyroid hormone receptor (TR) [13,14]. In the
nucleus, the facilitate binding of heterodimeric of TR and
retinoic acid X receptor to thyroid hormone response ele-
ments regulates the consequent gene transcription
through the action of co-repressors and co-activators
[12,13]. Several lines of evidence imply that mitogen-acti-
vated protein kinases (MAPKs) mediate multiple cellular
processes during normal brain development including
gene expression, migration or trafficking, metabolism,
differentiation, proliferation and apoptosis [15,16]. The
MAPKs are also called extracellular signal-regulated
kinases (ERK1 and ERK2) [16], which convey signals from
cell surface receptors to the nucleus. This process is impor-
tant in triggering the genomic response in neurons, and
integrates signals from other transduction pathways [17].
It has been reported that ERK inhibition in the hippocam-
pus led to disruption of spatial memory [18]. This is fur-
ther supported by a recent study from Alzoubi and
colleagues [19,20], showing that late long-term potentia-
tion (LTP) depends on new protein synthesis through
kinases-induced activation of cAMP-MAPK-CREB signal-
ing pathway, leading to alteration of synaptic structure.
LTP is a well-accepted synaptic model of learning and
memory [19,21] and thyroid hormone may play an indi-
rect role in LTP by affecting MAPKs independent of
nuclear thyroid receptors [16]. Firstly, thyroid hormone
activates G-protein-coupled receptors, which activates
ERK1/2, leading to CREB phosphorylation and cAMP
response element (CRE) transcription [16,22,23]. It has
been reported that MAPK/ERK activation is part of the
non-genomic action of thyroid hormone [12]. MAPK sig-
nal transduction cascade is activated by T4 and a plasma
membrane receptor on integrin αVβ3 via phospholipase
C and protein kinase Cα. The activated MAPK can translo-
cate to the nucleus to phosphorylate nuclear thyroid hor-
mone receptor TRβ1, step de-repress TR and modulate
intracellular protein trafficking of TR from cytoplasm to
nucleus [12]. Furthermore, thyroid hormone has also
been shown to regulate the expression and phosphoryla-
tion of ERK1/2 and CREB. Phosphorylation of ERK1/2
and CREB, in turn, causes important downstream effects
and regulates the expression of a variety of proteins, such
as immediate early genes, which are important in memory
[24]. Therefore, it is not surprising that ERK1/2 and CREB
play a critical role in LTP impairment following hypothy-
roidism [16,19,20,25].
However, little is know about how ID resulting in
hypothyroidism regulates developmental hippocampus
during lactational and adolescent period. It is widely
accepted that neocorticogenesis begins at about embry-
onic day 13 (E13) and the postnatal development and
maturation of the CNS persist for the lactation [from post-
natal day (PN) 1 to weaning] and adolescence (from
weaning to around PN 50) in rat [6]. So, transition from
gestation to adolescent period is critical for CNS develop-
ment and maturation. In adult rats, it has been shown
that, thyroid hormones reduction by perchlorate irrevers-
ibly impairs synaptic transmission [26], where the
restored thyroid hormone can not recover the develop-
mental CNS impairments. In line with this study, our
group has also previously shown in adult rats, develop-
mental ID and hypothyroidism impairs LTP in CA1
region [27]. In contrast to many researches on adult ani-
mals exposed to developmental thyroid hormone insuffi-
ciency, there are very few experimental studies available to
evaluate the alterations in early developmental period,
following developmental ID and hypothyroidism. So far,
it is still unclear whether ID and hypothyroidism have
similar effects on ERK1/2, CREB and their phosphorylated
fraction in hippocampal subregions in lactational and
adolescent animals. In the present study, we shown that,
in lactational and adolescent rats, hippocampal ERK1/2
and CREB are implicated in the brain impairment by




Wistar rats (250-280 g) were obtained from the Center for
Experimental Animals at China Medical University (Shen-
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yang, China) with a National Animal Use License number
of SCXK-LN 2003-0009. All experiments and surgical pro-
cedures were approved by the Animal Care and Use Com-
mittee at China Medical University, which complies with
the National Institutes of Health Guide for the Care and
Use of Laboratory Animals. All efforts were made to min-
imize the number of animals used and their suffering.
Rats were housed under the following standard condi-
tions temperature 24 ± 1°C and 12/12 h light/dark cycles
food and water was provided ad Libitum. Animals were
kept for 1 week before mating (: = 2:1). The day of the
vaginal plug was taken as gestational day (GD) 0. The
pregnant rats were randomly assigned into four groups (n
= 7 each): control group, 5 ppm PTU-treatment group, 15
ppm PTU-treatment group and iodine-deficient group.
Control group received tap water and normal diet (iodine
content: 470.50 ± 46.52 ng/g, measured by As3+-Ce4+ cat-
alytic spectrophotometry) during the experiment. Iodine-
deficient group was administered with iodine-deficient
diet (iodine content: 14.11 ± 1.96 ng/g) and tap water
from GD6 till PN28. PTU-treated groups were adminis-
tered 5 ppm and 15 ppm PTU (Sigma, St. Louis, MO) in
the drinking water and fed with normal diet (iodine con-
tent: 470.50 ± 46.52 ng/g) from GD6 to PN28. The animal
diet is made up of corn (46%), rice (40%), soybean
(13%), calcium carbonate (0.5%), and sodium chloride
(0.5%). For iodine-deficient diet, corn, rice, and soybean
were obtained from the severe iodine-deficient area.
On GD21, the control group gave birth to 12-13 pups per
litter. In contrast, 8-10 pups were born per litter in the
treated groups. Each litter was culled to nine-ten pups on
PN4 (same number of males and females in each group,
if possible). Pups were weaned and each cage housed only
two pups on PN25. Pup weights were recorded from PN3
to PN42. Eye opening was examined by daily observation
between PN15 and PN20. The percent of pups per litter
with both eyes open was calculated accordingly. Prior to
the sacrifice on PN14, PN21 (lactation), PN28 and PN42
(adolescence), the same number of pups were randomly
taken from different litters with a similar sex ratio in each
group and weighed.
Thyroid hormones
Thyroid hormone concentrations were determined via
blood sampling collected from heart puncture of 8-10
pups in each group on PN14, PN21, PN28 and PN42.
Briefly, after the pup was anesthetized using 99% ether
and laid on its back, a 25-gauge needle attached to a 1 ml
syringe was introduced at 10-30° from the horizontal axis
of the sternum into the thoracic cavity to collect heart
blood. Blood samples were centrifuged at 3,000 g for 5
min. Serum was then separated and stored at -70°C. All
the serum was assayed by super-sensitive chemilumines-
cence immunoassay (IMMULITE, Diagnostic Products
Corporation, Los Angeles, CA, USA) to measure thyroid
stimulating hormone (TSH), free triiodothyronine (FT3)
and free thyroxine (FT4). Hormones were measured in
300 μl aliquots. All samples were run in duplicate and the
intra- and inter-assay variations were below 10%. The sen-
sitivity of detection for TSH was 75 mIU/L, FT3 was 1.5-61
pmol/L, and FT4 was 3.9-77.2 pmol/L. Results below these
limits of quantification were recorded as 75 mIU/L (TSH),
1.5 pmol/L (FT3) and 3.9 pmol/L (FT4), respectively for
statistical purposes.
Nissl staining
On PN14, PN21, PN28, and PN42, 5 pups in each group
under deep anesthesia were intracardiac perfused with 50-
100 ml normal saline containing 0.02% heparin followed
by 200-400 ml 4% paraformaldehyde in 0.1 M potassium
phosphate buffer (pH 7.4). The fixed brains were embed-
ded in paraffin and sectioned into 6-μm-thick coronal sec-
tions on a microtome. Every third serial section was
collected on gelatin-coated microscope slides. After depar-
affinization in xylene for 10 min followed by 100% etha-
nol, the slides were washed in deionized water. Then, the
slides were performed with routine Nissl staining based
on the thionine technique and then analyzed under a
microscope. The hippocampal subregions of interest were
selected: CA1, CA3, and dentate gyrus (DG). All images
were obtained under the same conditions of light illumi-
nation, at a magnification of 400×, with the microscope
light source stabilized. For each group, quantitative data
were acquired from the hippocampus on both sides of the
brain. Cells with round and palely stained nuclei were
considered to be surviving cells, whereas shrunken neu-
rons with pyknotic nuclei were considered to be non-sur-
viving cells. Every fifth brain section was selected from
each animal and processed for cell counting in order to
obtain an overall mean value for subsequent statistical
analysis. Data were expressed as the number of surviving
cells per field. The experimenter was blind to the experi-
mental treatment of the individual animals during all data
measurements.
Western blot
On PN14, PN21, PN28 and PN42, 3 pups in each group,
including males and females, were deeply anesthetized
and euthanized by ether. Brains were removed and kept in
an ice-cold artificial cerebrospinal fluid (ACSF) composed
in miliMolar (mM): 124 mM NaCl, 3 mM KCl, 2 mM
CaCl, 1 mM MgSO4, 1.25 mM NaH2PO4, 26 mM
NaHCO3, and 10 mM glucose. According to the Paxions
and Wastson atlas of the rat brain [28], the CA1, CA3 and
DG regions of the hippocampus were immediately dis-
sected out on ice and frozen at -70°C. Tissue samples were
homogenized in 250 μl of buffered isotonic cocktail con-
taining protease and phosphatase inhibitors (50 mM Tris-
Hcl, 150 mM NaCl, 1% NP40, 0.1% SDS, 0.5% sodium
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deoxycholate, 10 mM NaF, 1 mM EGTA, 1 mM EDTA, and
0.2 mM PMSF). The samples were sonicated and incu-
bated on ice for 30 min, and centrifuged at 13,000 g for 10
min at 4°C. The supernatants were centrifuged again and
then removed. The total protein was estimated using
coomassie brilliant blue assay. The samples were stored at
-70°C until use.
Tissue lysates were diluted in sample buffer (0.312 mM
Tris-HCl (pH 6.8), 50% glycerol, 10% SDS, 25% β-mer-
captoethanol, and 0.25% bromophenol blue) to contain
the same concentration of protein (3 μg/μl) and were then
boiled at 100°C for 5 min. 10 μl aliquots of each sample
(containing 30 μg protein) were loaded onto 10% SDS-
acrylamide gels. Proteins were separated by the applica-
tion of a constant voltage of 100 V for 1.5 h and then
transferred onto nitrocellulose membranes at a constant
voltage of 10 V for 45 min. After blocking the aspecific
sites with PBS containing 0.1% Tween 20 (PBST) and 5%
defatted dried milk, membranes were washed and incu-
bated with rabbit anti-phospho-CREB monoclonal anti-
body (Cell Signaling Technology, Beverly, MA. 1:1000
dilution in PBS) for 2 h at room temperature. Rabbit pol-
yclonal antibody for glyceraldehyde phosphodehydroge-
nase (GAPDH, Santa Cruz Biotechnology, America.
1:1000 dilution in PBS) was used as a loading control. The
ratio of protein bands intensity to GAPDH band intensity
was compared among the different groups. Membranes
were washed and incubated in a horseradish peroxidase-
conjugated anti-rabbit IgG (Beijing Zhongshan Golden-
bridge Biotechnology Co., Ltd., China. 1:2500 dilution in
PBS) for 1 h at room temperature before reaction with
enhanced chemiluminescence (ECL) solution (Amer-
sham, GE Healthcare, UK). Initial control experiments
determined the optimal time of exposure to film, which
was maintained throughout the experimental procedure.
Membranes were exposed to film optimal time, and devel-
oped by hand. After developed and fixed, film was
scanned. Protein bands were quantified with an image-
analysis program (Gel Image System Ver. 4.00) and
recorded with net optical density (NOD) corrected for
background chemiluminescence. For all Western blots, on
each gel GAPDH lanes were reserved for a quality control
sample. The signals from target bands on a gel were nor-
malized to the average signal for the quality control sam-
ple bands to simplify comparison across gels and reduce
inter-gel variability.
Membranes were washed in restore Western blotting strip-
ping buffer (Pierce Biotechnology, Inc., USA) for 15 min
at room temperature after all the steps, and then washed
in PBST. Following the operating instructions, we incu-
bated the membrane with new SuperSignal West Working
Solution and exposed it to film. If no signal was detected
using a 5-min exposure, the HRP conjugate was success-
fully removed from the antigen or primary antibody. The
membranes were stripped and re-incubated in rabbit anti-
phospho-ERK1/2 monoclonal antibody, rabbit anti-CREB
monoclonal antibody, and rabbit anti-ERK1/2 mono-
clonal antibody (all from Cell Signaling Technology, Bev-
erly, MA; 1:1000 dilution in PBS) for 2 h at room
temperature in turn. After incubation with primary anti-
bodies, the membranes were washed and incubated in the
horseradish peroxidase-conjugated anti-rabbit IgG (Bei-
jing Zhongshan Goldenbridge Biotechnology Co., Ltd.,
China. 1:2500 dilution in PBS) for 1 h at room tempera-
ture before reaction with ECL solution respectively. Fol-
lowing the films were developed, fixed, and scanned, the
protein band intensities were quantified with an image-
analysis program.
Statistics
Results were expressed as mean ± SEM. All analyses were
carried out using the SPSS 11.5 software. For western
blots, all of the values were normalized with GAPDH,
which served as the internal control. The target band
intensities in the treatment groups were normalized to
those of the control group. The data differences among
the multiple groups were analyzed using one-way analysis
of variance (ANOVA). If F was significant, Tukey test was




Numerous studies have shown that PTU treatment
reduces offspring body weight [25,29,30]. Our data
shown that the offspring's body weights in iodine-defi-
cient, 15 ppm and 5 ppm PTU-treatment groups were sta-
tistically significant lower than the controls from PN3 to
PN42 (P < 0.05, Table 1). Eye opening is a parameter that
reflects the early physiological development of rats. Pups
open their eyes normally between PN15 and PN19 [30].
ID and 15 ppm PTU-treatment delayed the pup eye open-
ing to PN20. Further, comparing with the controls, the
iodine-deficient and 15 ppm PTU-treated pups had a sig-
nificantly lower eye opening percentage with both eye
open per litter on PN17 and PN18 (P < 0.05, Fig. 1.).
Dose-dependent reductions in thyroid hormones with
concomitant elevations in TSH were observed in hypothy-
roid offspring by many researchers [25]. Interestingly and
in line with this statement, our data showed that the off-
spring displayed hypothyroxinemia in iodine-deficient
group (reduced FT4 with no significant reduction in TSH)
and hypothyroidism in 15 ppm and 5 ppm PTU-treat-
ment groups. TSH levels were increased significantly in 15
ppm and 5 ppm PTU-treatment offspring Vs controls (P <
0.05, Table 2.). The iodine-deficient and 15 ppm PTU-
treatment groups had significantly lower serum FT3 and
FT4 than the controls on PN14, PN21 and PN28 (P < 0.05,
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Table 2.). On PN42, the concentrations of serum FT3, FT4
and TSH in iodine-deficient and PTU-treatment groups
were restored. Taken together, our results demonstrate
that the iodine-deficient and 15 ppm PTU-treatment
caused pup ID and hypothyroidism with developmental
delay.
ID and hypothyroidism increase hippocampal neuronal 
loss
To investigate whether or not hippocampal neuronal sur-
vival is impaired by ID and hypothyroidism, histological
examination of hippocampal neurons was performed on
Nissl-stained sections. The results reveal greater nuclear
breakdown in the hippocampal neurons of offspring with
low circulating thyroid hormone levels, in the CA1 (Addi-
tional file 1), CA3 (Additional file 2), and DG (Additional
file 3) regions on PN14, PN21, PN28, and PN42. The
mean number of surviving cells in the hippocampus of
the iodine-deficient and 15 ppm PTU-treated rats was sig-
nificantly reduced compared to controls (P < 0.05). These
findings suggest that ID and hypothyroidism led to mor-
phological damage in the hippocampus. Assessment of
the simple effects of group showed that neuronal loss was
increased at each time point in the hippocampus of rats
exposed to the iodine-deficient or PTU-adulterated diet.
ID and hypothyroidism reduce t-ERK1/2 and p-ERK1/2
Regulated by thyroid hormone and the role that they play
in the hippocampus, ERK1/2 are important in the genera-
tion of learning and memory [16,19,20]. In the present
study, we detected t-ERK1/2 and p-ERK1/2 changes in the
pups following developmental ID and hypothyroidism
Table 1: ID and PTU-induced hypothyroidism reduced pups body weight (g)
Time N Control 5 ppm-PTU 15 ppm-PTU ID
PN3 259 8.37 ± 0.12 7.06 ± 0.09 * 6.73 ± 0.11 *# 5.86 ± 0.08 *#Δ
PN7 252 13.79 ± 0.22 11.02 ± 0.17 * 10.66 ± 0.19 * 7.39 ± 0.15 *#Δ
PN10 231 20.13 ± 0.40 15.12 ± 0.16 * 14.29 ± 0.33 * 8.58 ± 0.22 *#Δ
PN14 217 26.43 ± 0.48 19.53 ± 0.24 * 18.09 ± 0.39 *# 10.43 ± 0.26 *#Δ
PN18 171 35.55 ± 0.59 25.96 ± 0.48 * 22.57 ± 0.53 *# 12.93 ± 0.46 *#Δ
PN21 140 44.83 ± 0.80 28.64 ± 0.73 * 25.05 ± 0.68 *# 14.41 ± 0.61 *#Δ
PN25 101 56.80 ± 1.39 38.97 ± 2.04 * 32.33 ± 1.27 *# 17.95 ± 1.04 *#Δ
PN28 101 74.22 ± 1.74 49.56 ± 1.97 * 37.14 ± 2.07 *# 21.41 ± 1.28 *#Δ
PN31 71 100.58 ± 2.52 69.31 ± 3.28 * 53.69 ± 4.27 *# 26.56 ± 1.69 *#Δ
PN35 71 126.30 ± 2.88 90.26 ± 3.85 * 72.17 ± 5.75 *# 40.94 ± 2.03 *#Δ
PN42 45 155.86 ± 6.11 127.09 ± 3.99 * 112.33 ± 7.40 * 69.41 ± 3.33 *#Δ
The pup weights of iodine-deficient, 15 ppm and 5 ppm PTU-treatment groups were significantly lower than controls from PN3 to PN42. Each 
values represents mean ± SEM. *P < 0.05, as compared to control group. #P < 0.05, as compared to 5 ppm PTU-treatment group. ΔP < 0.05, as 
compared to 15 ppm PTU-treatment group.
Table 2: Pup hormonal profile
Hormone Time Control 5 ppm-PTU 15 ppm-PTU ID
TSH (mUI/L) PN14 0.064 ± 0.029 1.713 ± 1.195 * 2.218 ± 0.587 * 0.142 ± 0.013 #Δ
PN21 0.052 ± 0.019 0.754 ± 0.538 * 1.990 ± 1.003 *# 0.246 ± 0.111 Δ
PN28 0.077 ± 0.023 0.908 ± 1.030 * 2.329 ± 1.378 *# 0.129 ± 0.038 Δ
PN42 0.074 ± 0.043 0.059 ± 0.031 0.065 ± 0.039 0.111 ± 0.049 *#Δ
FT3 (pmol/L) PN14 3.093 ± 1.384 2.097 ± 0.401 * 1.540 ± 0.000 * 1.555 ± 0.021 *
PN21 7.250 ± 1.205 9.823 ± 5.322 3.649 ± 1.229 *# 1.985 ± 0.346 *#
PN28 13.310 ± 0.924 12.399 ± 2.823 6.879 ± 3.621 *# 6.095 ± 3.828 *#
PN42 12.696 ± 4.882 13.105 ± 3.192 10.947 ± 3.282 13.520 ± 1.596
FT4 (pmol/L) PN14 25.025 ± 6.060 7.997 ± 0.939 * 6.610 ± 0.935 * 8.850 ± 1.202 *
PN21 33.225 ± 14.561 11.545 ± 6.173 * 10.000 ± 2.436 * 13.400 ± 0.707 *
PN28 31.330 ± 6.527 10.968 ± 2.227 * 9.885 ± 2.184 * 12.430 ± 1.432 *
PN42 41.155 ± 11.792 36.540 ± 7.826 41.150 ± 15.463 34.990 ± 9.212
The circulating levels of TSH were increased in PTU-induced hypothyroidism pups, while there were no significant differences in iodine-deficient 
pups on PN14, PN21 and PN28. ID and PTU-induced hypothyroidism decreased the serum FT3 and FT4 levels on PN14, PN21 and PN28. On PN42, 
the concentrations of serum FT3, FT4 and TSH in iodine-deficient and PTU-treatment groups were restored gradually. Each values represents mean 
± SEM (n = 8-10 for each group). *P < 0.05, as compared to control group. #P < 0.05, as compared to 5 ppm PTU-treatment group. ΔP < 0.05, as 
compared to 15 ppm PTU-treatment group.
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using western blot approach. Both t-ERK1/2 and p-ERK1/
2 were measured in CA1, CA3 and DG regions on PN14,
PN21, PN28 and PN42 (Fig. 2 and Fig. 3, respectively). In
CA1 and CA3 regions of the hippocampus, ID and
hypothyroidism significantly reduced t-ERK1 (P44) or t-
ERK2 (P42) (P < 0.05). p-ERK1 and p-ERK2 were signifi-
cantly lower on PN21, PN28 and PN42 (P < 0.05). On the
other hand, p-ERK1/2 was hardly detected on PN14. This
might be due to lower t-ERK in early postnatal period in
pups, and thus p-ERK1/2 signal becomes too weak to cap-
ture. In the DG region, however, ID and hypothyroidism
did not change t-ERK1/2 or p-ERK1/2 expression.
ID and hypothyroidism reduce t-CREB and p-CREB
As a downstream target molecule of ERK1/2, CREB plays
a critical role in the generation of protein synthesis-
dependent long-term changes in the brain [19] and is nec-
essary for the fear-associated memory [31]. In order to
investigate the effects of ID and hypothyroidism on CREB,
t-CREB and p-CREB were detected via western blot. In the
present study, t-CREB and p-CREB were clearly expressed
in CA1, CA3 and DG regions on PN14, PN21, PN28 and
PN42 (Fig. 4 and Fig. 5). However, the signals of p-CREB
were very weak on PN14. ID and hypothyroidism signifi-
cantly reduced both t-CREB (Fig. 4Ab) and p-CREB (Fig.
5Ab) in CA1, CA3 and DG regions (P < 0.05).
Discussion
The major findings of this study are that, in lactation and
adolescent stage of development rats, developmental ID
and hypothyroidism (15 ppm PTU) significantly reduced
the mean number of surviving cells in hippocampus and
decreased ERK1/2 and CREB expression in hippocampal
CA1 and CA3; even after the thyroid hormones back to
normal, surviving cells, ERK1/2 and CREB were still lower
than the controls. The present study demonstrates that
developmental ID and hypothyroidism down-regulate
hippocampal ERK1/2 and CREB in lactational and adoles-
cent rats.
Our previous study has shown that ID was still a serious
public health problem in China [32]. Given so many Chi-
ID and PTU-induced hypothyroidism delayed the eye opening in offspringFigure 1
ID and PTU-induced hypothyroidism delayed the eye opening in offspring. The ratio of iodine-deficient and 15 ppm 
PTU-treatment pups within a litter with both eyes open was significantly lower than controls on PN17 and PN18. Each bar rep-
resents the mean ± SEM (control group: n = 6; 5 ppm treatment group: n = 6; 15 ppm treatment group: n = 6; iodine-deficient 
group: n = 7). *P < 0.05, as compared to control. #P < 0.05, as compared to 5 ppm PTU-treatment group. ΔP < 0.05, as com-
pared to 15 ppm PTU-treatment group.
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Western blot analysis shows the decreased t-ERK1/2 following ID and hypothyroidism (n = 3 for each group)Figure 2
Western blot analysis shows the decreased t-ERK1/2 following ID and hypothyroidism (n = 3 for each group). 
The levels of t-ERK1/2 in ID and hypothyroidism groups were significantly lower than controls in CA1 and CA3 regions on 
PN14 (A), PN21 (B), PN28 (C) and PN42 (D). (a) Representative blots of t-ERK1/2 in hipocampal CA1, CA3 and DG regions 
of control, 5 ppm PTU-treatment, 15 ppm PTU-treatment and iodine-deficient groups. (b and c) t-ERK1 and t-ERK2 levels. 
Each bar represents the mean ± SEM. *P < 0.05, as compared to control. #P < 0.05, as compared to 5 ppm PTU-treatment 
group. ΔP < 0.05, as compared to 15 ppm PTU-treatment group.
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nese children exposed to developmental ID, this study
sought to make three lactational and adolescent animal
models to mimic the developmental exposure to ID and
hypothyroidism. Many lines of literature using adult ani-
mal models have demonstrated that developmental
hypothyroidism alters synaptic function in the hippocam-
pus [16,19-21,25,27,33-35]. In agreement with these
studies, the lactational and adolescent rats in this study
have an irreversible impairment in hippocampal ERK1/2
and CREB following developmental exposure to ID and
hypothyroidism. This is because that, during these devel-
opmental periods, the mother is the only source of iodine
for the fetus and neonate [5-7,35,36]. Therefore, maternal
ID leads to maternal and filial hypothyroxinemia. Taking
together, developmental periods during pregnancy and
lactation are critical in the brain development.
Thyroid hormone is well known to regulate morphologi-
cal and biochemical alterations in brain during critical
periods of brain development. This regulation can be
done by genomic, posttranslational, and direct actions on
neural substrates. Therefore, thyroid hormone is a funda-
mental factor that regulates normal development of the
CNS. Logically, thyroid hormone insufficiency during
early brain development is detrimental to synaptic trans-
mission in hippocampus and to a cellular and behavioral
model of learning and memory [2,5,8]. In need, our pre-
vious study has clearly demonstrated that ID-exposure
lowers the children IQs in China [32]. Experimentally, we
have also shown the ID can lead to an inhibition of LTP
in the rat CA1 area [27].
It is well known that MAPK mediates neuronal metabo-
lism, differentiation and proliferation [15,16]. Also, the
persisting alteration in developmental brain involves
changes in myelination and migration patterns of neu-
rons [37-41]. The present study further confirmed the
hypothesis that developmental ID and hypothyroidism
induce irreversible impairment of two key proteins
expression in the CA1 and CA3 regions, where both
ERK1/2 and CREB expression was significantly reduced in
either total protein level or phorsphorylated fraction. In
agreement with our findings, Gilbert and colleagues
observed the irreversibly CNS impairments in rats
induced by developmental hypothyroidism from GD6 to
PN30 [8,25,26,30]. This study provides us a clue to
Western blot analysis shows the decreased p-ERK1/2 following ID and hypothyroidism (n = 3 for each group)Figure 3
Western blot analysis shows the decreased p-ERK1/2 following ID and hypothyroidism (n = 3 for each group). 
The levels of p-ERK1/2 in ID and hypothyroidism groups were significantly lower than controls in CA1 and CA3 regions on 
PN21 (A), PN28 (B) and PN42 (C). (a) Representative blots of p-ERK1/2 in hipocampal CA1, CA3 and DG regions of control, 
5 ppm PTU-treatment, 15 ppm PTU-treatment and iodine-deficient groups. (b and c) p-ERK1 and p-ERK2 levels. Each bar rep-
resents the mean ± SEM. *P < 0.05, as compared to control. #P < 0.05, as compared to 5 ppm PTU-treatment group. ΔP < 0.05, 
as compared to 15 ppm PTU-treatment group.
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explore the mechanism by which thyroid hormone regu-
lates brain development during lactational and adolescent
periods.
As a member of MAPK, ERK1/2 is a critical memory-
related protein in the generation of learning and memory.
Thyroid hormone activates G-protein-coupled receptors,
leads to ERK1/2 phosphorylation, and in turn enhances
the transcription of some proteins that are important in
memory [16]. It has been shown that hypothyroidism
reduces the basal p-ERK1/2 in hippocampal CA1 region
without affecting t-ERK1/2 [16,19,25]. In the DG region,
however, hypothyroidism had no effect on t-ERK1/2 and
p-ERK1/2 [16,19,25]. In the lactational and adolescent
rats, here we show that t-ERK1/2 and p-ERK1/2 in iodine-
deficient, 15 ppm PTU-treatment and 5 ppm PTU-treat-
ment groups in CA1 and CA3 regions were significantly
lower than controls; while there was no difference in DG
Western blot analysis shows the decrease levels of t-CREB following ID and Hypothyroidism (n = 3 for each group)Figure 4
Western blot analysis shows the decrease levels of t-CREB following ID and Hypothyroidism (n = 3 for each 
group). The levels of t-CREB in ID and hypothyroidism groups were significantly lower than controls on PN14 (A), PN21 (B), 
PN28 (C) and PN42 (D). (a) Representative blots of t- CREB in hipocampal CA1, CA3 and DG regions of control, 5 ppm PTU-
treatment, 15 ppm PTU-treatment and iodine-deficient groups. (b) t- CREB levels. Each bar represents the mean ± SEM. *P < 
0.05, as compared to control. #P < 0.05, as compared to 5 ppm PTU-treatment group. ΔP < 0.05, as compared to 15 ppm PTU-
treatment group.
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region. This difference might be due to the different cell
types of neurons in the different regions. In the DG
region, the granule cells are more resistant to conditioned
stimulus than the pyramidal cells [16]. This is in line with
the importance of the CA1 and CA3 in the learning and
memory generation. Recently, it is reported that MAPK
genes are the direct targets of thyroid hormone [37,42]
and MAPK activation is part of the non-genomic action of
thyroid hormone [12]. Unlike the T3-dependent genomic
mechanism, the non-genomic pathway involves T4 not T3.
In present study, ID and hypothyroidism caused low T4
concentration in the lactational and adolescent rats. It is
reported that in PTU treated pups, serum T4 concentration
is negatively correlated with cerebrocortical type II 5'-dei-
odinase (D2) activity, a sensitive marker of tissue thyroid
status and an indicator of brain's compensatory response
to maintain cerebrocortical T3 [43]. Since T3 is correlated
with synaptic response, in the present study, we speculate
that the reduced serum FT4 may increase D2 activity,
decrease cerebrocortical T3 concentration, and lead to
bound-TR reduction. Taken together, ERK1/2 might be
down-regulated by developmental ID and hypothy-
roidism via non-genomic pathway. Different from the
present study, Calloni et al. reported that hypothyroidism
promoted an increase in p-ERK1/2 [15]. It might be attrib-
uted to difference of the method on establishing hypothy-
roid animal model or the concentration of medicine.
Calloni et al. administered pregnant rats with 0.02%
methimazole (MMI) in drinking water from GD10 to the
birth [15]. Since the neocorticogenesis and maturation of
the CNS persist for the adolescence in rat [6], the early
developmental impairments may be minor and reversi-
ble. Therefore, the increased p-ERK1/2 might be ascribed
to the recovered morphological and physiological
changes because of the termination of administration at
birth.
Another key protein for the long-term memory processes
is CREB. The activation of CREB and CREB-dependent
transcriptional pathway is essential for memory consoli-
dation [23,44]. Different from increased p-CREB in thy-
roid hormone treated neural cells [45], in the present
study, developmental ID and hypothyroidism signifi-
cantly lowered both t-CREB and p-CREB in CA1, CA3 and
DG regions. It has been proposed that p-CREB decrease
might attribute to protein reduction of t-CREB, Ca2+/
Camodulin dependent protein kinase IV (CaMKIV), and
adenylyl cyclase type I (ACI), or elevation of calcineurin
[19,46]. In addition, TR activation can antagonize CREB-
mediated transcription and inhibit the phosphorylation
of CREB [47]. So far, the detailed mechanism by which
developmental ID and hypothyroidism regulate CREB is
still unclear. Since CREB is a downstream target molecule
of ERK1/2, our present data imply that developmental ID
and hypothyroidism may induce p-ERK1/2 reduction,
which in turn lead to p-CREB reduction. However, we can
not exclude the involvement of genomic pathway, where
thyroid hormone modulates the CREB by regulating the
transcriptions of CaMKIV.
Moreover, the number and morphology of neuron in hip-
pocampus are affected by neonatal and adult hypothy-
roidism [48,49]. As a marker of neuronal development,
Nissl body diminishes when neuronal impairment. We
found here that the number of surviving neuronal cells in
hippocampus in iodine-deficient and 15 ppm PTU-treat-
ment groups were significantly lower than the controls.
Importantly, the reduction of Nissle bodies in the devel-
Western blot analysis shows the decrease levels of p-CREB following ID and Hypothyroidism (n = 3 for each group)Figure 5
Western blot analysis shows the decrease levels of p-CREB following ID and Hypothyroidism (n = 3 for each 
group). The levels of p-CREB in ID and hypothyroidism groups were significantly lower than controls on PN21 (A), PN28 (B) 
and PN42 (C). (a) Representative blots of p-CREB in hipocampal CA1, CA3 and DG regions of control, 5 ppm PTU-treatment, 
15 ppm PTU-treatment and iodine-deficient groups. (b) p-CREB levels. Each bar represents the mean ± SEM. *P < 0.05, as com-
pared to control. #P < 0.05, as compared to 5 ppm PTU-treatment group. ΔP < 0.05, as compared to 15 ppm PTU-treatment 
group.
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opmental ID and hypothyroidism fits very well with the
decreased protein production of ERK1/2 and CREB. This
might be due to the decrease in cell number, and to a
lower expression of the investigated genes in each neuron.
Therefore, our observation on Nissl bodies further con-
firmed the irreversible CNS impairments following devel-
opmental ID and hypothyroidism.
In summary, this study has shed some light on one aspect
of the ID/hypothyroidism-induced learning and memory
impairment. The following questions are still unan-
swered: how does thyroid hormone regulate ERK and
CREB? Why is there more reduction of p-CREB in DG
region than p-ERK1/2? How do ERK1/2 and CREB regu-
late LTP production? Is ERK protein regulation due to a
specific gene-expression modulation or are related to a
general decrease in gene expression and/or protein syn-
thesis following hypothyroidism? Further investigations
are needed to answer these questions.
Conclusion
Our previous study has confirmed the impairment of LTP
induction following developmental ID and hypothy-
roidism [26]. The present study has further shown that, in
lactational and adolescent rats, developmental ID and
hypothyroidism induce irreversible reduction of ERK1/2
and CREB in hippocampal CA1 and CA3 regions. In con-
clusion, ERK1/2 and CREB may play an important role in
ID and hypothyroidism-induced brain impairment in lac-
tational and adolescent rats.
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